Washington University in St. Louis (WU)

Megan A. Buchanan, PhD

Ph.D Candidate

My doctoral research interest centers around investigating if altered neural transmission in brainstem-spinal pathways drives maladaptive neural plasticity in spinal sensorimotor pathways and their ...

Craig A. Buchman, MD

Department Head

Ear and Hearing

Kathleen K. Bucholz, MPH, PhD

Professor of Psychiatry

Etiology and course of substance use, problems and disorders in youth, young adult and older adult populations, including the interplay of genes and environment and differences across ...

Jacob M. Buchowski, MD, MS

Professor of Orthopaedic Surgery

Dr. Buchowski's clinical interests include metatastic spine disease and tumors of the spine; degenerative disorders of the cervical, thoracic, and lumbar spine; spine trauma; and minimally invasive ...

William Buchser, PharmD, PhD

Idiopathic diseases (particularly neuro-degenerative and oncologic) continue to make diagnosis and treatment difficult due to their undefined nature. Many of these diseases have a heritable ...

Philip J. Budge, MD, PhD

Associate Professor of Medicine

Global elimination of LF and other neglected tropical diseases. My current work focuses on development of diagnostic tools for these diseases that can be used in the context of global public health programs.

Mahal Bugay, BS

Graduate Fellow

I am broadly interested in how ecological context affects plant–microbe interactions, and how microbes impact the communities and ecosystems in which they occur.

Jeremy D. Buhler, PhD

Professor of Computer Science and Engineering

My research concerns algorithms for biological sequence analysis. I am especially interested in accelerating sequence analysis tools to deal with the emerging demands of next-generation sequencing, ...

Maggie H. Bui, BS

DBBS Graduate Research Assistant

Type 1 diabetes; stem cell biology

Ashenafi S. Bulle, DVM, MSC, PhD

Instructor in Medicine

KRAS mutations are found in over 90% of pancreatic ductal adenocarcinoma (PDAC) cases, with KRAS^G12D being the most prevalent, making it a key therapeutic target. While recent KRAS ...